Want to create an interactive transcript for this episode?
Podcast: CME
Episode: Advances in the Treatment and Management of MASH: More Options, More Decisions
Description:
Host: Mary E. Rinella, MD, FAASLD
Guest: Naga Chalasani, MD, FAASLD
Guest: Mazen Noureddin, MD, MHSc
Join us for a CME online broadcast replay of a live satellite symposium from ACG 2024, where experts discuss MASLD/MASH, a serious disease that is both chronic and progressive. What’s most concerning is that MASLD/MASH will soon be the most common indication for liver transplantation and a major driver of the development of liver cancer. Until recently there was no liver-directed therapy for this disease, and the metabolic benefits of pharmacologic modification of body weight were underappreciated. This ac...